December 23, 2020 | 18:56 (GMT+7)
Additional 17 volunteers injected with Vietnamese COVID-19 vaccine
Seventeen more volunteers were injected with Nanocovax, the first COVID-19 vaccine developed by Vietnam, by the Military Medical University in the morning of December 22.
The people, who are among 60 volunteers selected for the first phase human trial, each received a dose of 25mcg. They have been under medical monitoring at the university for 72 hours.
    |
 |
|
A volunteer registering for the trial (Photo: vietnamnet.v) |
The first three volunteers were vaccinated on December 17. They are now in stable conditions and under health monitoring in their localities. The three will get the second jabs 28 days after the first injection.
The university is scheduled to increase the dose to 50mcg for three other volunteers.
Some 300-400 volunteers have so far registered for the clinical trials of COVID-19 vaccine.
Developed by the Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical University, Nanocovax is Vietnam's first COVID-19 candidate vaccine to reach the human trial stage.
The test will last for 56 days from the day given of the first injection. The participants will be under medical monitoring for six months.
The Nanogen Pharmaceutical Biotechnology JSC has spent 20 billion VND (865,946 USD) buying a health insurance package for the volunteers.
If the trials show good results, the drug-maker plans to administer Nanocovax to the public in May 2021.
Apart from Nanocovax, Vietnam has several other COVID-19 candidate vaccines being developed by Vabiotech, Polyvac, and the Institute of Vaccines and Medical Biologicals.
Source: VNA